Are you able to provide me some references of drugs skipping trials? I am interested in reading up on it. It would be a pretty big deal for RCE to skip trials and most likely great for us shareholders but seems a little bit of a stretch given the drug itself RECCE 327 is a new type of drug, that being synthetic polymer based antibiotic, hopefully we find out soon!
Accelerated Approval for RECCE® 327, page-6
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $115.9M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 52.0¢ | 49.0¢ | $164.9K | 323.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28482 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 27141 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |